NasdaqGM - Delayed Quote USD
Cerus Corporation (CERS)
1.2900
-0.0700
(-5.15%)
At close: May 9 at 4:00:00 PM EDT
1.2992
+0.01
+(0.71%)
After hours: May 9 at 7:46:25 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.03 | -0.02 | -0.1 | -0.05 |
| Low Estimate | -0.04 | -0.03 | -0.13 | -0.11 |
| High Estimate | -0.01 | -0.01 | -0.06 | 0.02 |
| Year Ago EPS | -0.03 | -0.02 | -0.11 | -0.1 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 51.2M | 53.29M | 208.57M | 225.59M |
| Low Estimate | 48.2M | 49M | 195M | 210M |
| High Estimate | 55.5M | 57.05M | 223.3M | 245.7M |
| Year Ago Sales | 45.08M | 46.02M | 180.27M | 208.57M |
| Sales Growth (year/est) | 13.57% | 15.80% | 15.70% | 8.16% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.04 | -0.03 | -0.01 | -0.05 |
| EPS Actual | -0.03 | -0.02 | -0.01 | -0.04 |
| Difference | 0.01 | 0.01 | 0 | 0.01 |
| Surprise % | 14.29% | 33.33% | 20.00% | 20.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.02 | -0.1 | -0.05 |
| 7 Days Ago | -0.03 | -0.03 | -0.11 | -0 |
| 30 Days Ago | -0.03 | -0.03 | -0.11 | -0 |
| 60 Days Ago | -0.03 | -0.02 | -0.09 | -0.02 |
| 90 Days Ago | -0.01 | 0 | -0.06 | -0.01 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CERS | 11.10% | -16.65% | 9.09% | 50.00% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/21/2025 |
| Maintains | Stifel: Buy to Buy | 10/17/2024 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 5/3/2024 |
| Initiated | Craig-Hallum: Buy | 4/12/2024 |
| Reiterates | Stephens & Co.: Equal-Weight to Equal-Weight | 3/7/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 3/6/2024 |
Related Tickers
PACB Pacific Biosciences of California, Inc.
1.1200
-6.67%
RCEL AVITA Medical, Inc.
6.97
-25.29%
CTSO Cytosorbents Corporation
0.8710
+0.11%
LAB Standard BioTools Inc.
1.0700
-4.04%
SSKN STRATA Skin Sciences, Inc.
2.4600
-4.65%
ATEC Alphatec Holdings, Inc.
12.21
-4.16%
INGN Inogen, Inc.
6.24
-1.73%
OFIX Orthofix Medical Inc.
12.11
-1.62%
RPID Rapid Micro Biosystems, Inc.
3.0800
+25.71%
BFLY Butterfly Network, Inc.
2.2300
-1.76%